Author Correction: Inhibitory potential of triazines and hydrazinyl thiazole substituted chromones against the HslVU protease/chaperone complex, a novel drug target

M. Hamid, S. Aurangzeb, Y. Rashid, S. Shamim, U. Salar, M.K. Azim, K.M. Khan, S. Bashir

Department of Biochemistry, University of Karachi, Karachi, Pakistan.

---

• Pharmacology

Correction to: European Review for Medical and Pharmacological Sciences 2022; 26 (22): 8567-8575. DOI: 10.26355/eurrev_202211_30392-PMID: 36459037-published online on November 30, 2022.

After publication, the authors applied some corrections to the text:

– Dr. U. Salar’s affiliation has been corrected as follows: Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.

– The values in the row “Binding energy with HsIV (Kcal/mol)” Table I have been corrected as follows: from -8.4 into -9.0; from -8.6 into -9.2; from -8.0 into -8.5 from -8.3 into -8.7.

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

Inhibitory potential of triazines and hydrazinyl thiazole substituted chromones against the HslVU protease/chaperone complex, a novel drug target

Free PDF Download